Analysis of hydroxychloroquine dosage in hospitalized COVID-19 patients shows low-dose benefits and high-dose risks.

Hydroxychloroquine and antimalarials control skin rashes and joint pain, help prevent blood clots, and help you live longer with lupus.

Hydroxychloroquine is ineffective and unsafe in the treatment of COVID-19: This is the belief held by millions of Americans and many healthcare professionals. After months of randomized clinical tr… ...

The first randomized clinical trial testing hydroxychloroquine as an early treatment for mild covid-19 found the drug was no better than a placebo in patients who were not hospitalized.

A handful of states have passed legislation allowing ivermectin to be sold and purchased over-the-counter (OTC) -- and other ...

Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday ...

Tracking hydroxychloroquine misinformation: How an unproven COVID-19 treatment ended up being endorsed by Trump Donald Trump has touted the anti-malarial drug as a COVID-19 "game changer." ...

President Trump said he would take hydroxychloroquine again “if he thought he was exposed” to the novel coronavirus, even after extensive testing has proven that … ...

This multicenter study investigates the association between hydroxychloroquine (HCQ) dosage and COVID-19 mortality among ...

Timeline: Tracking Trump alongside scientific developments on hydroxychloroquine The president touts the drug, but it hasn't proven effective against COVID-19.

Hydroxychloroquine, and the similar drug chloroquine, are among the most effective approved prescription treatments for lupus and other autoimmune diseases.

Studies that showed hydroxychloroquine as beneficial were flawed or, like the Henry Ford study, included another medication helpful against COVID-19.